BAC
Bank of America Corporation
BAC's fundamentals are strong: its operating margin rose 5 points to 35% and revenue grew 15%. At 12x earnings, it's trading in line with its usual 13x. Analysts expect earnings growth.
VINP
Vinci Compass Investments Ltd.
There isn't enough reported data to score VINP yet.
BAC Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
BAC's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like BAC.
VINP Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Stable | |
| N/A | |
| N/A |
VINP's revenue is currently healthy, and its profitability is stable. Free cash flow and net leverage aren't meaningful measures for financial services companies like VINP.
BAC PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.4x | $39.50 | -22% |
| Forward | 10x | $50.51 | — |
| Current | 12x | $50.51 | — |
| Fair | 13x | $53.81 | +6.5% |
| Expensive | 15x | $62.23 | +23% |
Historical ranges are pointers, not guarantees.
BAC's PE is in its fair range at 12x. If earnings grow as analysts expect, today's price would be 10x next year's earnings, in its cheap range.
VINP PE Valuation
VINP has no meaningful PE right now: it lost money over the past year.
BAC Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Moderate |
BAC has the edge over VINP on the outlook, with more favorable earnings and revenue expectations.
VINP Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Decline | |
| Stable | |
| Strongly weakening | |
| Limited | |
| High |
Analysts expect VINP's earnings and profitability to decline, with its revenue holding steady.
BAC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $4.92 | +17% |
| Q3 2026 | $4.19 | +14% |
| Q2 2026 | $4.34 | +27% |
| Q1 2026 | $4.02 | +20% |
| Q4 2025 | $3.81 | +19% |
| Q3 2025 | $3.66 | +33% |
| Q2 2025 | $3.41 | +20% |
| Q1 2025 | $3.35 | +16% |
| Q4 2024 | $3.21 | +4.2% |
BAC has the stronger earnings trend. Trailing diluted EPS is up 14% for BAC versus VINP down 49%.
VINP Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q4 2024 | $0.38 | -49% |
| Q3 2024 | $0.59 | -18% |
| Q2 2024 | $0.55 | -35% |
| Q1 2024 | $0.75 | +5.6% |
| Q4 2023 | $0.74 | +4.2% |
| Q3 2023 | $0.72 | +2.9% |
| Q2 2023 | $0.85 | +35% |
| Q1 2023 | $0.71 | +9.2% |
VINP's earnings per share have fallen from their peak: $0.38 over the past year, against $0.85 in mid-2023.
BAC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $30B | +6.7% |
| Q2 2026 | $31.6B | +19% |
| Q1 2026 | $30.3B | +11% |
| Q4 2025 | $31.2B | +23% |
| Q3 2025 | $28.1B | +11% |
| Q2 2025 | $26.5B | +4.3% |
| Q1 2025 | $27.4B | +6% |
| Q4 2024 | $25.3B | +15% |
BAC's revenue has grown year over year for 10 quarters in a row: $30B last quarter, up 6.7% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 30% | -3.7 points |
| Q2 2026 | 37% | +7.6 points |
| Q1 2026 | 34% | +4.7 points |
| Q4 2025 | 40% | +12 points |
| Q3 2025 | 34% | +4.8 points |
| Q2 2025 | 29% | -0.7 points |
| Q1 2025 | 30% | +1.5 points |
| Q4 2024 | 28% | +14 points |
BAC has the edge over VINP on profitability, with a higher operating margin.
VINP Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $50.1M | +2.1% |
| Q1 2026 | $49.2M | +17% |
| Q4 2025 | $131.8M | +183% |
| Q3 2025 | $63.5M | +188% |
| Q2 2025 | $49M | +86% |
| Q1 2025 | $42M | +115% |
| Q4 2024 | $46.6M | +60% |
| Q3 2024 | $22.1M | +4.6% |
VINP has the edge over BAC on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 28% | +6.1 points |
| Q1 2026 | 32% | +3.4 points |
| Q4 2025 | 26% | N/A |
| Q3 2025 | -49% | -67 points |
| Q2 2025 | 21% | -17 points |
| Q1 2025 | 29% | -3.7 points |
| Q4 2024 | 18% | -15 points |
| Q3 2024 | 38% | -2.1 points |
VINP's operating margin was 28% last quarter, up 6.1 points from the same quarter a year ago.
BAC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$6.5B | -114% |
| Q2 2026 | $29B | +$38.2B |
| Q1 2026 | $41.8B | +$44B |
| Q4 2025 | -$22.9B | -189% |
| Q3 2025 | $46.9B | +$84.2B |
| Q2 2025 | -$9.1B | -150% |
| Q1 2025 | -$2.2B | +$13.4B |
| Q4 2024 | $25.9B | -21% |
BAC has the edge over VINP on cash flow, with more consistent year-over-year improvement.
VINP Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $10.9M | +6.6% |
| Q1 2026 | -$5M | -449% |
| Q4 2025 | $10.7M | +$11.5M |
| Q3 2025 | $18.3M | +$31.4M |
| Q2 2025 | $10.2M | -63% |
| Q1 2025 | $1.4M | -93% |
| Q4 2024 | -$802.1K | -108% |
| Q3 2024 | -$13.1M | -234% |
VINP's free cash flow was $35M over the past year, against −$2M the year before. Free cash flow isn't a meaningful measure for financial services companies like VINP.
BAC Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1% | -72M shares |
| 1 year | -5.3% | -405M shares |
| 3 years | -11% | -854M shares |
| 5 years | -15% | -1.3B shares |
| Available history | -24% | -2.2B shares |
BAC has the edge over VINP on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $6B |
| Q2 2026 | $6B |
| Q1 2026 | $7.2B |
| Q4 2025 | $6.3B |
| Q3 2025 | $5.3B |
| Q2 2025 | $5.3B |
| Q1 2025 | $4.5B |
| Q4 2024 | $3.5B |
BAC spent $25.6B buying back its own shares over the past year, up 37% from the year before.
VINP Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +4.4% | +2.9M shares |
| 1 year | +6.7% | +4.3M shares |
| 3 years | +20% | +11.6M shares |
| 5 years | +32% | +16.7M shares |
| Available history | +23% | +12.8M shares |
VINP has 68M diluted shares, up 6.7% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | $387,401 |
| Q3 2025 | $333,889 |
| Q2 2025 | $1.6M |
| Q1 2025 | $7.2M |
| Q4 2024 | $6.5M |
| Q3 2024 | $4M |
VINP spent $721,290 buying back its own shares over the past year, down 96% from the year before.
BAC Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 6.4x | High |
| Q2 2026 | 6.7x | High |
| Q1 2026 | 7.1x | High |
| Q4 2025 | 7.7x | High |
| Q3 2025 | 8.3x | High |
| Q2 2025 | 8.8x | High |
| Q1 2025 | 8.6x | High |
| Q4 2024 | 9.0x | High |
BAC's net debt is about 6.4 years of its operating earnings (EBITDA), down from 8.3 years a year ago. Net leverage isn't a meaningful measure for financial services companies like BAC.
VINP Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | 1.2x | Healthy |
| Q1 2026 | 1.4x | Healthy |
| Q4 2025 | 1.3x | Healthy |
| Q4 2024 | 3.3x | Elevated |
| Q3 2024 | 2.4x | Moderate |
| Q2 2024 | 2.8x | Moderate |
| Q1 2024 | 2.2x | Moderate |
| Q4 2023 | 2.5x | Moderate |
VINP has the edge over BAC on leverage, with a lower net debt burden relative to earnings.
BAC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 37.1 | Neutral |
| Stochastic | 4.9 | Oversold |
BAC's weekly RSI is 37 (neutral) and its Stochastic is 5 (oversold).
VINP Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 41.1 | Neutral |
| Stochastic | 8.0 | Oversold |
VINP's weekly RSI is 41 (neutral) and its Stochastic is 8 (oversold).
BAC PE vs Financial Services Sector
| Metric | BAC | Sector median | Relative |
|---|---|---|---|
| PE | 12x | 13x | 7.5% below |
| PE % | 40 | 63 | 23 pts below |
BAC is trading at 12x earnings, in line with the Financial Services sector's median of 13x.
VINP PE vs Financial Services Sector
| Metric | VINP | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 13x | — |
VINP has no meaningful PE right now: it lost money over the past year.
BAC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $52.1 | 3% below |
| 20 week MA | $57.8 | 13% below |
| 50 week MA | $54.7 | 7.7% below |
| 100 week MA | $50.5 | 0% below |
| 200 week MA | $42.5 | 19% above |
BAC has the edge over VINP on trend strength, trading above more of its moving averages.
VINP Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $9.87 | 11% below |
| 20 week MA | $9.74 | 9.5% below |
| 50 week MA | $10.7 | 18% below |
| 100 week MA | $10.5 | 16% below |
| 200 week MA | $10.3 | 14% below |
VINP is in a downtrend: it's below all five of its weekly moving averages, and 14% below its 200-week average.
BAC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $35.4 | $30.0 | -15% |
| 2021 | $30.0 | $44.4 | +48% |
| 2022 | $44.4 | $32.5 | -27% |
| 2023 | $32.5 | $33.7 | +3.7% |
| 2024 | $33.7 | $44.3 | +32% |
| 2025 | $44.3 | $56.2 | +27% |
| 2026 YTD | $56.2 | $50.5 | -10% |
BAC has the edge over VINP on returns for 2026, with the stronger performance.
VINP Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $17.1 | $11.2 | -34% |
| 2022 | $11.2 | $8.37 | -25% |
| 2023 | $8.37 | $11.0 | +31% |
| 2024 | $11.0 | $10.0 | -8.5% |
| 2025 | $10.0 | $13.1 | +31% |
| 2026 YTD | $13.1 | $8.81 | -33% |
VINP has finished lower in three of the last five years. It's down 33% so far in 2026.